Literature DB >> 22324502

The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population.

Marije J Hoornweg1, Mark J C Smeulders, Dirk T Ubbink, Chantal M A M van der Horst.   

Abstract

Haemangiomas are considered to be the most common tumours of infancy. However, despite their frequent occurrence the aetiological determinants of their development remain unknown. Identifying these factors may provide insight on their pathogenesis. We performed cross-sectional screening for haemangiomas in newborns (0-16 months of age) in the general Dutch population. Haemangioma-specific and pregnancy-related data were collected in children with a haemangioma. These data were compared in a case-control design using multivariable logistic regression analysis. Among 2204 newborns, 219 (9.9%) had a haemangioma. The male-to-female ratio was 1:2. The majority of haemangiomas were located on the trunk (37%). The general practitioners or medical specialists were consulted in only a minority of cases (<7%). Amniocentesis [odds ratio (OR) 3.6, 95% confidence interval (CI) 1.11, 11.42], breech presentation [OR 2.3, 95% CI 1.14, 4.44], being first-born [OR 1.55, 95% CI 1.03, 2.33] and a birthweight ≤2500 g [OR 4.95, 95% CI 1.63, 15.05] were independent factors associated with the development of a haemangioma. Duration of pregnancy did not differ between study groups. Our study showed that the prevalence of a haemangioma is 9.9% in the general (Dutch) population. Four factors appear relevant in the development of haemangiomas. These factors may provide clues to its pathogenesis.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22324502     DOI: 10.1111/j.1365-3016.2011.01214.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  19 in total

1.  Psychological comorbidities and compliance to interventional treatment of patients with cutaneous vascular malformations.

Authors:  Stephanie A Kenny; Nevin Majeed; Naista Zhand; Rafael Glikstein; Ronit Agid; Marlise P Dos Santos
Journal:  Interv Neuroradiol       Date:  2016-05-12       Impact factor: 1.610

Review 2.  Vascular anomalies: clinical perspectives.

Authors:  Joao Guilherme Amaral; Irene Lara-Corrales
Journal:  Pediatr Radiol       Date:  2022-01-05

Review 3.  Update on Treatment of Infantile Hemangiomas: What's New in the Last Five Years?

Authors:  Laura Macca; Domenica Altavilla; Luca Di Bartolomeo; Natasha Irrera; Francesco Borgia; Federica Li Pomi; Federico Vaccaro; Violetta Squadrito; Francesco Squadrito; Mario Vaccaro
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

4.  Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight.

Authors:  Katelyn R Anderson; Jennifer J Schoch; Christine M Lohse; Jennifer L Hand; Dawn M Davis; Megha M Tollefson
Journal:  J Am Acad Dermatol       Date:  2015-10-19       Impact factor: 11.527

5.  Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies.

Authors:  A Munden; R Butschek; W L Tom; J S Marshall; D M Poeltler; S E Krohne; A B Alió; M Ritter; D F Friedlander; V Catanzarite; A Mendoza; L Smith; M Friedlander; S F Friedlander
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

6.  Expression of Cathepsins B, D, and G in Infantile Hemangioma.

Authors:  Tinte Itinteang; Daria A Chudakova; Jonathan C Dunne; Paul F Davis; Swee T Tan
Journal:  Front Surg       Date:  2015-06-17

7.  Treatment of Infantile Hemangioma in Regional Hospitals With eHealth Support: Evaluation of Feasibility and Acceptance by Parents and Doctors.

Authors:  Marlies de Graaf; Joan Ee Totté; Harmieke van Os-Medendorp; Wilco van Renselaar; Corstiaan C Breugem; Suzanne Gma Pasmans
Journal:  JMIR Res Protoc       Date:  2014-11-03

8.  Pulsed dye laser and topical timolol gel versus pulse dye laser in treatment of infantile hemangioma: A double-blind randomized controlled trial.

Authors:  Ali Asilian; Fatemeh Mokhtari; Atefeh Sadat Kamali; Bahareh Abtahi-Naeini; Mohammad Ali Nilforoushzadeh; Shayan Mostafaie
Journal:  Adv Biomed Res       Date:  2015-11-30

9.  Evaluation of the Compliance, Acceptance, and Usability of a Web-Based eHealth Intervention for Parents of Children With Infantile Hemangiomas: Usability Study.

Authors:  Marlies de Graaf; Joan Totte; Corstiaan Breugem; Harmieke van Os-Medendorp; Suzanne Pasmans
Journal:  JMIR Res Protoc       Date:  2013-12-17

10.  Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.

Authors:  Jing Ge; Jiawei Zheng; Ling Zhang; Weien Yuan; Haiguang Zhao
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.